There was policy work, as I understand it, Madam Chair, that was done collectively. Some jurisdictions chose to pick that up individually, but there was no will among the group, as I understand it, to go forward together. I would say that there was an interest in 2004 in strengthening the evaluation and the real world safety and effectiveness. We have in fact created the Drug Safety and Effectiveness Network. Again, a number of the individual mechanisms have been followed up and many of them have been implemented.
On November 20th, 2012. See this statement in context.